Theophylline accelerates human granulocyte apoptosis not via phosphodiesterase inhibition

Journal of Clinical Investigation

Volumn 100, Issue 7, 1997, Pages 1677-1684

  Yasui, Kozo ^a   Hu, Bin ^a   Nakazawa, Takayuki ^a   Agematsu, Kazunaga ^a   Komiyama, Atsushi ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

bcl 2 protein; Cell death; Eosinophils; Fas antigen; Neutrophils

Indexed keywords

CYCLIC AMP; FAS ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 5; PHOSPHODIESTERASE; PROTEIN BCL 2; THEOPHYLLINE;

ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; ASTHMA; CELL SURVIVAL; CONTROLLED STUDY; DRUG MECHANISM; EOSINOPHIL; GRANULOCYTE; HUMAN; HUMAN CELL; INFLAMMATION; NEUTROPHIL; PRIORITY JOURNAL;

EID: 0030984157     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119692     Document Type: Article

References (36)

1. Wyllie, A.H., J.F.R. Kerr, and A.R. Currie. 1980. Cell death: the significance of apoptosis. Int. Rev. Cytol. 68:251-306.
2. Itoh, N., S. Yonehara, A. Ishii, M. Yonehara, S.-I. Mizushima, M. Sameshima, A. Hase, Y. Seto, and S. Nagata. 1991. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell. 66: 233-243.
3. Oehm, A., I. Behrmann, W. Falk, M. Pawlita, G. Manier, C. Klas, M. Lin-Weber, S. Richards, J. Dhein, B.C. Trauth, et al. 1992. Purification and molecular cloning of the APO-1 cell surface antigen, a memher of the tumor necrosis factor/nerve growth factor receptor superfamily. J. Biol. Chem. 267:10709-10715.
4. Debatin, K.M., C.K. Goldman, T.A. Waldmann, and P.H. Krammer. 1993. APO-1-induced apoptosis of leukemia cells from patients with adult T-cell leukemia. Blood. 81:2972-2977.
5. Iwai, K., T. Miyawaki, T. Takizawa, A. Konno, K. Ohta, A. Yachie, H. Seki, and N. Taniguchi. 1994. Differential expression of bcl-2 and susceptibility to anti-Fas-mediated cell death in peripheral blood lymphocytes, monocytes, and neutrophils. Blood. 84:1201-1208.
6. Matsumoto, K., R.P. Schleimer, H. Saito, Y. Iikura, and B.S. Bochner. 1995. Induction of apoptosis in human eosinophils by anti-Fas antibody treatment in vitro. Blood. 86:1437-1443.
7. Druilhe, A., Z. Cai, S. Haile, S. Chouaib, and M. Pretolani. 1996. Fas-mediated apoptosis in cultured human eosinophils. Blood. 87:2822-2830.
8. Rothenberg, M.E., W.F. Owen, Jr., D.S. Silberstein, J. Woods, R.J. Soberman, K.F. Austen, and R.L. Stevens. 1988. Human eosinophils have prolonged survival, enhanced functional properties, and become hypodense when exposed to human interleukin 3. J. Clin. Invest. 81:1986-1992.
9. Lopez, A.F., D.J. Williamson, J.R. Gamble, C.G. Begley, J.M. Harlan, S.J. Klebanoff, A. Waltersdorph, G. Wong, S.C. Clark, and M.A. Vadas. 1986. Recombinant human granulocyte-macrophage colony-stimulating factor stimulates in vitro mature human neutrophil and eosinophil function, surface receptor expression, and survival. J. Clin. Invest. 78:1220-1228.
10. Tai, P.C., and C.J. Spry. 1990. The effects of recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin-3 on the secretory capacity of human blood eosinophils. Clin. Exp. Immunol. 80:426-434.
11. Verhoef, G., and M. Boogaerts. 1991. Treatment with granulocyle-macrophage colony-stimulating factor and the adult respiratory distress syndrome. Am. J. Hematol. 36:285-287.
12. Tiegs, G., J. Barsig, B. Matiba, S. Uhlig, and A. Wendel. 1994. Potentiation by granulocyte macrophage colony-stimulating factor of lipopolysaccharide toxicity in mice. J. Clin. Invest. 93:2616-2622.
13. Djukanovic, R., J.P. Finnerty, C. Lee, S. Wilson, J. Madden, and S.T. Holgate. 1995. The effects of theophylline on mucosal inflammation in asthmatic airways: biopsy results. Eur. Respir. J. 8:831-833.
14. Sullivan, P., S. Bekir, Z. Jaffar, C. Page, P. Jeffery, and J. Costello. 1994. Anti-inflammatory effects of low-dose oral theophylline in atopic asthma. Lancet. 343:1006-1008.
15. Yasui, K., M. Yamazaki, M. Miyabayashi, T. Tsuno, and A. Komiyama. 1994. Signal transduction pathway in human polymorphonuclear leukocytes for chemotaxis induced by a chemotactic factor. J. Immunol. 152:5922-5927.
16. Her, E., J. Frazer, K.F. Austen, and W.F. Owen. 1991. Eosinophil hematopoietins antagonize the programmed cell death of eosinophils-cttokine and glucocorticoid effects on eosinophils maintained by endothelial cell conditioned medium. J. Clin. Invest. 88:1982-1987.
17. Tai, P.C., L. Sun, and C.J. Spry. 1991. Effects of IL-5, granulocyte/macrophage colony-stimulating factor (GM-CSF) and IL-3 on the survival of human blood eosinophils in vitro. Clin. Exp. Immunol. 85:312-316.
18. Stern, M., L. Meagher, J. Savill, and C. Haslett. 1992. Apoptosis in human eosinophils. Programmed cell death in the eosinophil leads to phagocytosis by macrophages and is modulated by IL-5. J. Immunol. 148:3543-3549.
19. Liles, W.C., and S.J. Klebanoff. 1995. Regulation of apoptosis in neutrophils - Fas track to death? J. Immunol. 155:3289-3291.
20. Weinberger, M. 1984. The pharmacology and therapeutic use of theophylline. J. Allergy Clin. Immunol. 73:525-540.
21. Pauwels, R. 1989. New aspects of the therapeutic potential of theophylline in asthma. J. Allergy Clin. Immunol. 83:548-553.
22. Calhoun, W.J., C.A. Stevens, and S.B. Lambert. 1991. Modulation of superoxide production of alveolar macrophages and peripheral blood mononudear cells by beta-agonists and theophylline. J Lab. Clin. Med. 117:514-522.
23. Crescioli, S., A. Spinazzi, M. Plebani, M. Pozzani, C.E. Mapp, P. Boschetto, and L.M. Fabbri. 1991. Theophylline inhibits early and late asthmatic reactions induced by allergens in asthmatic subjects. Ann. Allergy. 66: 245-251.
24. Nielson, C.P., J.J. Crawley, M.E. Morgan, and R.E. Vestal. 1988. Polymorphonuclear leukocyte inhibition by therapeutic concentrations of theophylline is mediated by cyclic 3′,5′ adenosine monophosphate. Am. Rev. Respir. Dis. 137:25-30.
25. Bryant, R.E., and M.C. Sutcliffe. 1974. The effect of 3′,5′ cyclic adenosine monophosphate on granulocyte adhesion. J. Clin. Invest. 54:1241-1244.
26. Tyagi, S.R., S.C. Olson, D.M. Burnham, and J.D. Lambeth. 1991. Cyclic AMP-elevating agents block chemoattractant activation of diradylglycerol generation by inhibiting phospholipase D activation. J. Biol. Chem. 266:3498-3504.
27. 2+ influx. J. Biol. Chem. 270:23816-23822.
28. Downey, O.P., E.L. Elson, B. Schwab, S.C. Erzurum, S.K. Young, and G.S. Worthen. 1991. Biophysical properties and microfilament assembly in neutrophils: modulation by cyclic AMP. J. Cell Biol. 114:1179-1190.
29. Quilliam, L.A., H. Mueller, B.P. Bohl, V. Prossnitz, L.A. Sklar, C.J. Der, and G.M. Bokoch. 1991. Rap1A is a substrate for cAMP-dependent protein kinase in human neutrophils. J. Immunol. 147:1628-1635.
30. Nielson, C.P., R.E. Vestal, R.J. Sturm, and P.R. Heasli. 1990. Effect of selective phosphodiesterase inhibitors on the polymorphonuclear leukocyte respiratory burst. J. Allergy Clin. Immunol. 86:801-808.
31. Barnes, P.J., and R.A. Pauwels. 1994. Theophylline in the management of asthma: time for reappraisal? Eur. Respir. J. 7:579-591.
32. Rossi, A.C., J.M. Cousin, I. Dransfield, M.F. Lawson, E.R. Chilvers, and C. Haslett. 1995. Agents that elevate cAMP inhibit human neutrophil apoptosis. Biochem. Biophys. Res. Commun. 217:892-899.
33. Yasui, K., A. Komiyama, T.F.P. Molski, and R.I. Sha'afi. 1994. Pentoxifylline and CD14 antibody additively inhibit priming of polymorphonuclear leukocytes for enhanced release of superoxide by lipopolysaccharide: possible mechanism of these actions. Infect. Immun. 62:922-927.
34. Belloc, F., C. Jaloustre, P. Dumain, F. Lacombe, M. Lenoble, and M.R. Boisseau. 1995. Effect of pentoxifylline on apoptosis of cultured cells. J. Cardiovase. Pharmacol. 25(Suppl.):71-74.
35. Hockenbery, D., G. Nunez, C. Millman, R.D. Shreiber, and S.J. Korsmeyer. 1990. Bcl-2, an inner mitochondrial protein that blocks programmed cell death. Nature (Lond.). 348:334-336.
36. Mentz, F., M.D. Mossalayi, F. Ouaaz, S. Baudet, F. Issaly, S. Ktorza, M. Semichon, J.-L. Binet, and H. Merle-Beral. 1996. Theophylline synergizes with chlorambucil in inducing apoptosis of B-chronic lymphocytic leukemia cells. Blood. 88:2172-2182.